Superworth

LENSAR EPS LNSR

Diluted earnings per share by quarter and over the last twelve months, from 2019.

Last 12 months, to Jun 30, 2026
−$0.33
Latest quarter, Q2 FY26
$0.10
Fiscal year 2025
−$2.90

LENSAR's earnings per share was −$0.33 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was $0.10.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$2.90n/a
FY2024−$2.72n/a
FY2023−$1.79n/a
FY2022−$1.97n/a
FY2021−$2.09n/a
FY2020−$9.05n/a
FY2019n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26$0.10n/a−$0.33
Q1 FY26$0.00n/a−$0.58
Q4 FY25−$0.12n/a−$2.90
Q3 FY25−$0.31n/a−$4.39
Q2 FY25−$0.15n/a−$4.21
Q1 FY25−$2.32n/a−$4.85
Q4 FY24−$1.61n/a−$2.72
Q3 FY24−$0.13n/a−$1.46
Q2 FY24−$0.79n/a−$1.56
Q1 FY24−$0.19n/a−$1.58
Q4 FY23−$0.35n/a−$1.79
Q3 FY23−$0.23n/a−$1.68

Against its peers

Companies in Medical - Instruments & Supplies nearest LENSAR's size, closest first, today.

CompanyEPS, 12 monthsGrowth
LNSRLENSAR−$0.33
KEQUKewaunee Scientific$2.76−33% a year
APTAlpha Pro Tech$0.41+24% a year
NEPHNephros$0.16+33% a year
PDEXPro DEX$4.11+52% a year
UTMDUtah Medical Products$3.28−12% a year
INFUInfuSystem$0.41+78% a year
EMBCEmbecta$1.47+3% a year
TCMDTactile Systems Technology$1.08+74% a year
MDXGMimedx$0.04−81% a year
MOVMovado$1.80+137% a year
Peer median$1.27

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on LENSAR

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.